{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T02:08:45Z","timestamp":1770689325987,"version":"3.49.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82473154, 82403274, 82172645 and 82372805"],"award-info":[{"award-number":["82473154, 82403274, 82172645 and 82372805"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82473154, 82403274, 82172645 and 82372805"],"award-info":[{"award-number":["82473154, 82403274, 82172645 and 82372805"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82473154, 82403274, 82172645 and 82372805"],"award-info":[{"award-number":["82473154, 82403274, 82172645 and 82372805"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"General Program of Clinical Research from the Nanjing Drum Tower Hospital","award":["2023-LCYJ-MS-23"],"award-info":[{"award-number":["2023-LCYJ-MS-23"]}]},{"name":"Jiangsu Province Basic Research Special Fund (Soft Science Research) Special Funding","award":["BK20240117"],"award-info":[{"award-number":["BK20240117"]}]},{"name":"Nanjing Municipal Special Fund for Health Science and Technology Development","award":["YKK24070"],"award-info":[{"award-number":["YKK24070"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2024M751404"],"award-info":[{"award-number":["2024M751404"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04136-y","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:52:50Z","timestamp":1756281170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Multi-marker model based on serum IL-10 predicts response to conversion immunochemotherapy in gastric cancer patients: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Xingzhou","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daming","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shichao","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongyuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefeng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxian","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"issue":"5","key":"4136_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41575-022-00726-3","volume":"20","author":"J Huang","year":"2023","unstructured":"Huang J, Lucero-Prisno DE 3rd, Zhang L, Xu W, Wong SH, et al. Updated epidemiology of Gastrointestinal cancers in East Asia. Nat Rev Gastroenterol Hepatol. 2023;20(5):271\u201387.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"4136_CR2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","volume":"20","author":"AP Thrift","year":"2023","unstructured":"Thrift AP, Wenker TN, El-Serag HB. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol. 2023;20(5):338\u201349.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"4136_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/cac2.12516","volume":"44","author":"FH Wang","year":"2024","unstructured":"Wang FH, Zhang XT, Tang L, Wu Q, Cai MY, et al. The Chinese society of clinical oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer Commun (Lond). 2024;44(1):127\u201372.","journal-title":"Cancer Commun (Lond)"},{"issue":"4suppl","key":"4136_CR4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1200\/JCO.2025.43.4_suppl.392","volume":"43","author":"L Shen","year":"2025","unstructured":"Shen L, Bai Y, Lin X, Li W, Wang J, et al. First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in patients (pts) with advanced gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma (GC\/GEJC\/EAC): 5-year (y) follow-up of Chinese Pts from checkmate 649. J Clin Oncol. 2025;43(4suppl):392\u2013392.","journal-title":"J Clin Oncol"},{"issue":"7","key":"4136_CR5","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1200\/JCO.22.02331","volume":"41","author":"MA Shah","year":"2023","unstructured":"Shah MA, Kennedy EB, Alarcon-Rozas AE, Alcindor T, Bartley AN, et al. Immunotherapy and targeted therapy for advanced gastroesophageal cancer: ASCO guideline. J Clin Oncol. 2023;41(7):1470\u201391.","journal-title":"J Clin Oncol"},{"issue":"2","key":"4136_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347.","journal-title":"Eur J Cancer"},{"issue":"14","key":"4136_CR7","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.3390\/cancers15143662","volume":"15","author":"V Tsagkalidis","year":"2023","unstructured":"Tsagkalidis V, Blaszczyk MB, In H. Interpretation of Tumor Response Grade following Preoperative Therapy for Gastric Cancer: An Overview. Cancers (Basel). 2023;15(14):3662.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4136_CR8","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1186\/s12885-022-10125-1","volume":"22","author":"MY Lai","year":"2022","unstructured":"Lai MY, Kang SY, Sun YT, Quan TT, Lu SX, et al. Comparison of response evaluation criteria in solid tumors and tumor regression grade in evaluating the effect of preoperative systemic therapy of gastric cancer. BMC Cancer. 2022;22(1):1031.","journal-title":"BMC Cancer"},{"issue":"15","key":"4136_CR9","doi-asserted-by":"publisher","first-page":"12192","DOI":"10.3390\/ijms241512192","volume":"24","author":"XH Tang","year":"2023","unstructured":"Tang XH, Wu XL, Gan XJ, Wang YD, Jia FZ, et al. Using Normalized Carcinoembryonic Antigen and Carbohydrate Antigen 19 to Predict and Monitor the Efficacy of Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer. Int J Mol Sci. 2023;24(15):12192.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4136_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3390\/cancers16040757","volume":"16","author":"K Marcisz-Grzanka","year":"2024","unstructured":"Marcisz-Grzanka K, Kotowicz B, Nowak A, Winiarek M, Fuksiewicz M, et al. Interleukin-6 as a Predictive Factor of Pathological Response to FLOT Regimen Systemic Treatment in Locally Advanced Gastroesophageal Junction or Gastric Cancer Patients. Cancers (Basel). 2024;16(4):757.","journal-title":"Cancers (Basel)"},{"key":"4136_CR11","doi-asserted-by":"publisher","first-page":"156389","DOI":"10.1016\/j.cyto.2023.156389","volume":"172","author":"M Sk\u00f3rzewska","year":"2023","unstructured":"Sk\u00f3rzewska M, Piku\u0142a A, G\u0119ca K, Mlak R, Rawicz-Pruszy\u0144ski K, et al. Systemic inflammatory response markers for prediction of response to neoadjuvant chemotherapy in patients with advanced gastric cancer. Cytokine. 2023;172:156389.","journal-title":"Cytokine"},{"issue":"14","key":"4136_CR12","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1158\/1078-0432.CCR-22-0413","volume":"28","author":"M Zhu","year":"2022","unstructured":"Zhu M, Chen C, Foster NR, Hartley C, Mounajjed T, et al. Pembrolizumab in combination with neoadjuvant chemoradiotherapy for patients with resectable adenocarcinoma of the gastroesophageal junction. Clin Cancer Res. 2022;28(14):3021\u201331.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4136_CR13","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.1038\/s41467-023-40480-x","volume":"14","author":"J Wei","year":"2023","unstructured":"Wei J, Lu X, Liu Q, Fu Y, Liu S, et al. Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial. Nat Commun. 2023;14(1):4904.","journal-title":"Nat Commun"},{"issue":"10294","key":"4136_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398(10294):27\u201340.","journal-title":"Lancet"},{"issue":"4","key":"4136_CR15","doi-asserted-by":"publisher","first-page":"e225557","DOI":"10.1001\/jamanetworkopen.2022.5557","volume":"5","author":"JX Lin","year":"2022","unstructured":"Lin JX, Tang YH, Lin GJ, Ma YB, Desiderio J, et al. Association of adjuvant chemotherapy with overall survival among patients with locally advanced gastric Cancer after neoadjuvant chemotherapy. JAMA Netw Open. 2022;5(4):e225557.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"4136_CR16","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1038\/s41416-023-02217-x","volume":"128","author":"A Athauda","year":"2023","unstructured":"Athauda A, Nankivell M, Langer R, Pritchard S, Langley RE, et al. Pathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trials. Br J Cancer. 2023;128(11):2036\u201343.","journal-title":"Br J Cancer"},{"issue":"1","key":"4136_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s10120-017-0743-4","volume":"21","author":"N Ikoma","year":"2018","unstructured":"Ikoma N, Blum M, Estrella JS, Das P, Hofstetter WL, et al. Evaluation of the American joint committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy. Gastric Cancer. 2018;21(1):74\u201383.","journal-title":"Gastric Cancer"},{"issue":"1","key":"4136_CR18","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1038\/s41467-023-38837-3","volume":"14","author":"E Garralda","year":"2023","unstructured":"Garralda E, Laurie SA, Seymour L, de Vries EGE. Towards evidence-based response criteria for cancer immunotherapy. Nat Commun. 2023;14(1):3001.","journal-title":"Nat Commun"},{"issue":"3","key":"4136_CR19","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","volume":"18","author":"L Seymour","year":"2017","unstructured":"Seymour L, Bogaerts J, Perrone A, Ford R, Schwartz LH, et al. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol. 2017;18(3):e143\u201352.","journal-title":"Lancet Oncol"},{"key":"4136_CR20","doi-asserted-by":"publisher","first-page":"101381","DOI":"10.1016\/j.eclinm.2022.101381","volume":"46","author":"Y Yang","year":"2022","unstructured":"Yang Y, Jiang X, Liu Y, Huang H, Xiong Y, et al. Elevated tumor markers for monitoring tumor response to immunotherapy. EClinicalMedicine. 2022;46:101381.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"4136_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41746-024-01043-6","volume":"7","author":"Y Li","year":"2024","unstructured":"Li Y, Wu X, Fang D, Luo Y. Informing immunotherapy with multi-omics driven machine learning. NPJ Digit Med. 2024;7(1):67.","journal-title":"NPJ Digit Med"},{"issue":"1","key":"4136_CR22","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1038\/s41467-022-31535-6","volume":"13","author":"J Kong","year":"2022","unstructured":"Kong J, Ha D, Lee J, Kim I, Park M, et al. Network-based machine learning approach to predict immunotherapy response in cancer patients. Nat Commun. 2022;13(1):3703.","journal-title":"Nat Commun"},{"issue":"4","key":"4136_CR23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41587-021-01070-8","volume":"40","author":"D Chowell","year":"2022","unstructured":"Chowell D, Yoo SK, Valero C, Pastore A, Krishna C, et al. Improved prediction of immune checkpoint Blockade efficacy across multiple cancer types. Nat Biotechnol. 2022;40(4):499\u2013506.","journal-title":"Nat Biotechnol"},{"key":"4136_CR24","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/s43018-024-00772-7","volume":"8","author":"TG Chang","year":"2024","unstructured":"Chang TG, Cao Y, Sfreddo HJ, Dhruba SR, Lee SH, et al. LORIS robustly predicts patient outcomes with immune checkpoint Blockade therapy using common clinical, pathologic and genomic features. Nat Cancer. 2024;8:1158\u201375.","journal-title":"Nat Cancer."},{"issue":"8","key":"4136_CR25","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41581-024-00838-w","volume":"20","author":"BA Nguyen","year":"2024","unstructured":"Nguyen BA, Alexander MR, Harrison DG. Immune mechanisms in the pathophysiology of hypertension. Nat Rev Nephrol. 2024;20(8):530\u201340.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"4136_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41569-024-01062-6","volume":"22","author":"LL Camargo","year":"2024","unstructured":"Camargo LL, Rios FJ, Montezano AC, Touyz RM. Reactive oxygen species in hypertension. Nat Rev Cardiol. 2024;22(1):20\u201337.","journal-title":"Nat Rev Cardiol."},{"issue":"13","key":"4136_CR27","first-page":"2589","volume":"117","author":"EC Murray","year":"2021","unstructured":"Murray EC, Nosalski R, MacRitchie N, Tomaszewski M, Maffia P, et al. Therapeutic targeting of inflammation in hypertension: from novel mechanisms to translational perspective. Cardiovasc Res. 2021;117(13):2589\u2013609.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"4136_CR28","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/cvr\/cvy252","volume":"115","author":"SM Krishnan","year":"2019","unstructured":"Krishnan SM, Ling YH, Huuskes BM, Ferens DM, Saini N, et al. Pharmacological Inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension. Cardiovasc Res. 2019;115(4):776\u201387.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"4136_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41593-023-01497-z","volume":"27","author":"MM Santisteban","year":"2024","unstructured":"Santisteban MM, Schaeffer S, Anfray A, Faraco G, Brea D, et al. Meningeal interleukin-17-producing T cells mediate cognitive impairment in a mouse model of salt-sensitive hypertension. Nat Neurosci. 2024;27(1):63\u201377.","journal-title":"Nat Neurosci"},{"issue":"6","key":"4136_CR30","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1161\/CIRCRESAHA.119.314758","volume":"126","author":"L Xiao","year":"2020","unstructured":"Xiao L, do Carmo LS, Foss JD, Chen W, Harrison DG. Sympathetic enhancement of memory T-Cell homing and hypertension sensitization. Circ Res. 2020;126(6):708\u201321.","journal-title":"Circ Res"},{"issue":"10","key":"4136_CR31","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s41423-022-00902-0","volume":"19","author":"G Morris","year":"2022","unstructured":"Morris G, Gevezova M, Sarafian V, Maes M. Redox regulation of the immune response. Cell Mol Immunol. 2022;19(10):1079\u2013101.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"4136_CR32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.immuni.2011.12.007","volume":"36","author":"GJ van der Windt","year":"2012","unstructured":"van der Windt GJ, Everts B, Chang CH, Curtis JD, Freitas TC, et al. Mitochondrial respiratory capacity is a critical regulator of CD8\u2009+\u2009T cell memory development. Immunity. 2012;36(1):68\u201378.","journal-title":"Immunity"},{"issue":"1","key":"4136_CR33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1186\/s12885-019-5828-5","volume":"19","author":"K Takada","year":"2019","unstructured":"Takada K, Kashiwagi S, Asano Y, Goto W, Takahashi K, et al. Verification of the effects of calcium channel blockers on the immune microenvironment of breast cancer. BMC Cancer. 2019;19(1):615.","journal-title":"BMC Cancer"},{"issue":"14","key":"4136_CR34","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.3390\/ijms20143458","volume":"20","author":"IVG Silva","year":"2019","unstructured":"Silva IVG, de Figueiredo RC, Rios DRA. Effect of Different Classes of Antihypertensive Drugs on Endothelial Function and Inflammation. Int J Mol Sci. 2019;20(14):3458.","journal-title":"Int J Mol Sci"},{"key":"4136_CR35","doi-asserted-by":"publisher","first-page":"113287","DOI":"10.1016\/j.biopha.2022.113287","volume":"153","author":"D Felkle","year":"2022","unstructured":"Felkle D, Jarczy\u0144ski M, Kaleta K, Zi\u0119ba K, Nazimek K. The Immunomodulatory effects of antihypertensive therapy: A review. Biomed Pharmacother. 2022;153:113287.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"4136_CR36","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1093\/annonc\/mdu274","volume":"25","author":"B Suh","year":"2014","unstructured":"Suh B, Park S, Shin DW, Yun JM, Keam B, et al. Low albumin-to-globulin ratio associated with cancer incidence and mortality in generally healthy adults. Ann Oncol. 2014;25(11):2260\u20136.","journal-title":"Ann Oncol"},{"issue":"12","key":"4136_CR37","doi-asserted-by":"publisher","first-page":"e005670","DOI":"10.1136\/jitc-2022-005670","volume":"10","author":"M Zheng","year":"2022","unstructured":"Zheng M. Serum albumin: a pharmacokinetic marker for optimizing treatment outcome of immune checkpoint blockade. J Immunother Cancer. 2022;10(12):e005670.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"4136_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41698-022-00267-7","volume":"6","author":"SK Yoo","year":"2022","unstructured":"Yoo SK, Chowell D, Valero C, Morris LGT, Chan TA. Pre-treatment serum albumin and mutational burden as biomarkers of response to immune checkpoint Blockade. NPJ Precis Oncol. 2022;6(1):23.","journal-title":"NPJ Precis Oncol"},{"issue":"9","key":"4136_CR39","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.3390\/jcm13092456","volume":"13","author":"S Suzuki","year":"2024","unstructured":"Suzuki S, Taguchi Y, Kitabayashi T, Sato N, Kaya H, et al. Serum Albumin as an Independent Predictor of Long-Term Survival in Patients with Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Treated with Nivolumab. J Clin Med. 2024;13(9):2456.","journal-title":"J Clin Med"},{"key":"4136_CR40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.addr.2018.07.011","volume":"130","author":"EN Hoogenboezem","year":"2018","unstructured":"Hoogenboezem EN, Duvall CL. Harnessing albumin as a carrier for cancer therapies. Adv Drug Deliv Rev. 2018;130:73\u201389.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"4136_CR41","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","volume":"9","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Tao L, Qiu J, Xu J, Yang X, et al. Tumor biomarkers for diagnosis, prognosis and targeted therapy. Signal Transduct Target Ther. 2024;9(1):132.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"4136_CR42","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.4251\/wjgo.v16.i5.1737","volume":"16","author":"CM Zhou","year":"2024","unstructured":"Zhou CM, Zhao SH. Evaluation of the value of combined detection of tumor markers CA724, carcinoembryonic antigen, CA242, and CA19-9 in gastric cancer. World J Gastrointest Oncol. 2024;16(5):1737\u201344.","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"4136_CR43","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41392-024-01886-1","volume":"9","author":"M He","year":"2024","unstructured":"He M, Zhou X, Wang X. Glycosylation: mechanisms, biological functions and clinical implications. Signal Transduct Target Ther. 2024;9(1):194.","journal-title":"Signal Transduct Target Ther"},{"key":"4136_CR44","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/1477-7819-12-397","volume":"12","author":"Z Sun","year":"2014","unstructured":"Sun Z, Zhang N. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy. World J Surg Oncol. 2014;12:397.","journal-title":"World J Surg Oncol"},{"issue":"5","key":"4136_CR45","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1158\/2159-8290.CD-23-0857","volume":"14","author":"M An","year":"2024","unstructured":"An M, Mehta A, Min BH, Heo YJ, Wright SJ, et al. Early immune remodeling steers clinical response to First-Line chemoimmunotherapy in advanced gastric Cancer. Cancer Discov. 2024;14(5):766\u201385.","journal-title":"Cancer Discov"},{"issue":"1","key":"4136_CR46","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1038\/s41467-022-32570-z","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Jia K, Sun Y, Zhang C, Li Y, et al. Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment. Nat Commun. 2022;13(1):4851.","journal-title":"Nat Commun"},{"issue":"5","key":"4136_CR47","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ccell.2022.04.005","volume":"40","author":"A Jaiswal","year":"2022","unstructured":"Jaiswal A, Verma A, Dannenfelser R, Melssen M, Tirosh I, et al. An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes. Cancer Cell. 2022;40(5):524\u2013e544525.","journal-title":"Cancer Cell"},{"issue":"3","key":"4136_CR48","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.immuni.2024.02.007","volume":"57","author":"A Franken","year":"2024","unstructured":"Franken A, Bila M, Mechels A, Kint S, Van Dessel J, et al. CD4\u2009+\u2009T cell activation distinguishes response to anti-PD-L1\u2009+\u2009anti-CTLA4 therapy from anti-PD-L1 monotherapy. Immunity. 2024;57(3):541\u2013e558547.","journal-title":"Immunity"},{"issue":"7","key":"4136_CR49","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.ccell.2023.06.006","volume":"41","author":"TM Carroll","year":"2023","unstructured":"Carroll TM, Chadwick JA, Owen RP, White MJ, Kaplinsky J, et al. Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinoma. Cancer Cell. 2023;41(7):1222\u2013e12411227.","journal-title":"Cancer Cell"},{"issue":"7972","key":"4136_CR50","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41586-023-06299-8","volume":"620","author":"C Guo","year":"2023","unstructured":"Guo C, You Z, Shi H, Sun Y, Du X, et al. SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity. Nature. 2023;620(7972):200\u20138.","journal-title":"Nature"},{"issue":"6633","key":"4136_CR51","doi-asserted-by":"publisher","first-page":"eabg2752","DOI":"10.1126\/science.abg2752","volume":"379","author":"M He","year":"2023","unstructured":"He M, Roussak K, Ma F, Borcherding N, Garin V, et al. CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses. Science. 2023;379(6633):eabg2752.","journal-title":"Science"},{"key":"4136_CR52","doi-asserted-by":"publisher","first-page":"1274431","DOI":"10.3389\/fimmu.2023.1274431","volume":"14","author":"Y Hou","year":"2023","unstructured":"Hou Y, Li X, Yang Y, Shi H, Wang S, et al. Serum cytokines and neutrophil-to-lymphocyte ratio as predictive biomarkers of benefit from PD-1 inhibitors in gastric cancer. Front Immunol. 2023;14:1274431.","journal-title":"Front Immunol"},{"issue":"4","key":"4136_CR53","doi-asserted-by":"publisher","first-page":"e20220686","DOI":"10.1084\/jem.20220686","volume":"220","author":"Q Sun","year":"2023","unstructured":"Sun Q, Zhao X, Li R, Liu D, Pan B, et al. STAT3 regulates CD8\u2009+\u2009T cell differentiation and functions in cancer and acute infection. J Exp Med. 2023;220(4):e20220686.","journal-title":"J Exp Med"},{"issue":"12","key":"4136_CR54","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1016\/j.immuni.2021.11.004","volume":"54","author":"BS Hanna","year":"2021","unstructured":"Hanna BS, Lla\u00f3-Cid L, Iskar M, Roessner PM, Klett LC, et al. Interleukin-10 receptor signaling promotes the maintenance of a PD-1(int) TCF-1(+) CD8(+) T cell population that sustains anti-tumor immunity. Immunity. 2021;54(12):2825\u2013e28412810.","journal-title":"Immunity"},{"issue":"6","key":"4136_CR55","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41590-021-00940-2","volume":"22","author":"Y Guo","year":"2021","unstructured":"Guo Y, Xie YQ, Gao M, Zhao Y, Franco F, et al. Metabolic reprogramming of terminally exhausted CD8(+) T cells by IL-10 enhances anti-tumor immunity. Nat Immunol. 2021;22(6):746\u201356.","journal-title":"Nat Immunol"},{"issue":"11","key":"4136_CR56","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1038\/s41587-023-02060-8","volume":"42","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Chen J, Andreatta M, Feng B, Xie YQ, et al. IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases. Nat Biotechnol. 2024;42(11):1693\u2013704.","journal-title":"Nat Biotechnol."},{"issue":"7","key":"4136_CR57","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.cell.2025.02.002","volume":"188","author":"Z Chang","year":"2025","unstructured":"Chang Z, Guo X, Li X, Wang Y, Zang Z, et al. Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization. Cell. 2025;188(7):1842-1857.e20.","journal-title":"Cell."}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04136-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04136-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04136-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:53:30Z","timestamp":1757444010000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04136-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4136"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04136-y","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"23 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As illustrated in the methodology, this study has been approved by the Ethics Committee of Nanjing Drum Tower Hospital, affiliated with Nanjing University Medical School (Approval number: 2025-0099-01). The study was conducted in accordance with the principles of the Declaration of Helsinki. We hereby declare that all patients participating in this study have been informed of the project and our study has obtained their consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"621"}}